VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.8377
-0.0303 (-3.49%)
Jun 27, 2025, 4:00 PM - Market closed
VolitionRx Employees
VolitionRx had 85 employees as of December 31, 2024. The number of employees decreased by 25 or -22.73% compared to the previous year.
Employees
85
Change (1Y)
-25
Growth (1Y)
-22.73%
Revenue / Employee
$15,392
Profits / Employee
-$282,638
Market Cap
86.30M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
VNRX News
- 15 days ago - Volition Announces MARS Consortium Clinical Study Suggests Nu.Q® H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure - PRNewsWire
- 23 days ago - Volition Announces Two Oral Presentations at Asian Meeting of Animal Medicine Specialties - PRNewsWire
- 5 weeks ago - VolitionRx Limited Announces Successful Detection of Nucleosomes in Cats - PRNewsWire
- 6 weeks ago - VolitionRX Limited (VNRX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - VolitionRx Limited Announces First Quarter 2025 Financial Results and Business Update - PRNewsWire
- 6 weeks ago - VolitionRx Limited Schedules First Quarter 2025 Earnings Conference Call and Business Update - PRNewsWire
- 7 weeks ago - VolitionRX Limited: Outlines broad strategy to become the 'NETs company' worldwide through licensing and updates progress of Nu.Q® NETs test adoption - PRNewsWire
- 2 months ago - VolitionRX Limited: Revolutionizing the diagnosis and monitoring of life-altering diseases for both humans and animals in multi-billion dollar markets - PRNewsWire